Company intelligence / Profile preview

CGC Genomics Consults

Ownership: Private
Development stage: Preclinical

Overview

CGC Genomics has developed Qnomx, an AI-powered genomics report interpretation platform that automates the interpretation of complex genomic data for cancer care. The platform has shown an 85% reduction in interpretation time and enables processing 7x more cases without additional resources[2].

Therapeutic areas: Oncology
Modalities: AI-powered genomics interpretation
Industry: Digital Health Medical Devices

Partnerships

Labor Becker MVZ eGbR

Beyond the preview

Go deeper on CGC Genomics Consults.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CGC Genomics Consults.

Explore the full profile